Back to bill feed
H.R. 11045 (119th Congress)In committee
Sign in to get alerts

To amend the 21st Century Cures Act and the Public Health Service Act to ensure that expenses relating to the acquisition or use of devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances, including test strips, are allowable expenses under certain grant programs.

Read the record. Not the rhetoric.

See how your representatives voted on this bill.

DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.

Alignment with your views

Sign in and take the values quiz to see how this bill lines up with what you've said.

Summary

AI-generated summary — verify against full text

Based on the bill's title, it would amend the 21st Century Cures Act and the Public Health Service Act to make expenses for acquiring or using devices that detect fentanyl, xylazine, and other emerging adulterant substances, including test strips, allowable expenses under certain grant programs. The bill was referred to the House Committee on Energy and Commerce; the full text was not available for review, so specific grant programs and provisions cannot be confirmed.

Values analysis

Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.

How your representatives voted

Sign in to see how your representatives voted on this bill.